Indolent non-Hodgkin lymphoma treatment in the new drugs era

Chin Clin Oncol. 2020 Dec;9(6):81. doi: 10.21037/cco.2020.01.01. Epub 2020 Feb 11.

Authors

Luis Miguel Juárez-Salcedo¹, Samir Dalia²

Affiliations

¹ Hematology Department, Gregorio Marañón University Hospital, Madrid, Spain. Dr.luisjuarez@gmail.com.
² Hematology/Oncology, Mercy Clinic Oncology and Hematology-Joplin, Joplin, MO, USA. sdalia@gmail.com.

PMID: 32075392
DOI: 10.21037/cco.2020.01.01

No abstract available

MeSH terms

Antineoplastic Agents / therapeutic use*
Humans
Lymphoma, Non-Hodgkin* / drug therapy

Substances

Antineoplastic Agents